List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Left Ventricular Dysfunction - Overview
Left Ventricular Dysfunction - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Left Ventricular Dysfunction - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Left Ventricular Dysfunction - Companies Involved in Therapeutics Development
Innopharmax Inc
Mesoblast Ltd
Quantum Genomics SA
Shanghai Life Science & Technology
Takeda Pharmaceutical Co Ltd
Viscofan BioEngineering
Left Ventricular Dysfunction - Drug Profiles
AlloCSC-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
carvedilol CR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
firibastat IR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Left Ventricular Dysfunction - Dormant Projects
Left Ventricular Dysfunction - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Left Ventricular Dysfunction, H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Left Ventricular Dysfunction - Pipeline by Innopharmax Inc, H2 2020
Left Ventricular Dysfunction - Pipeline by Mesoblast Ltd, H2 2020
Left Ventricular Dysfunction - Pipeline by Quantum Genomics SA, H2 2020
Left Ventricular Dysfunction - Pipeline by Shanghai Life Science & Technology, H2 2020
Left Ventricular Dysfunction - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2020
Left Ventricular Dysfunction - Pipeline by Viscofan BioEngineering, H2 2020
Left Ventricular Dysfunction - Dormant Projects, H2 2020
Left Ventricular Dysfunction - Discontinued Products, H2 2020

List of Figures
Number of Products under Development for Left Ventricular Dysfunction, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020

Companies Mentioned
• Innopharmax Inc
• Mesoblast Ltd
• Quantum Genomics SA
• Shanghai Life Science & Technology
• Takeda Pharmaceutical Co Ltd
• Viscofan BioEngineering